<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(2)</volume><submitter>Shin E</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>The effects of asthma, chronic obstructive pulmonary disease (COPD), or asthma-COPD overlap (ACO) on coronavirus disease 2019 (COVID-19) remain unclear.&lt;h4>Objective&lt;/h4>We aimed to investigate the effects of chronic obstructive airway diseases such as asthma, COPD, and ACO on COVID-19.&lt;h4>Methods&lt;/h4>In total, 5625 hospitalized patients with COVID-19 were divided into asthma, COPD, ACO, and control groups. A multivariate logistic regression analysis was performed to identify factors affecting the COVID-19 mortality rate. To find out whether chronic obstructive airway diseases such as asthma, COPD, and ACO affect COVID-19 mortality, 1:4 matching was performed, except for the ACO group alone due to a small number of patients.&lt;h4>Results&lt;/h4>The mortality rates of asthma, </pubmed_abstract><journal>Asia Pacific allergy</journal><pagination>e21</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9066077</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Impact of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap on the prognosis of coronavirus disease 2019.</pubmed_title><pmcid>PMC9066077</pmcid><pubmed_authors>Cho YS</pubmed_authors><pubmed_authors>Moon HB</pubmed_authors><pubmed_authors>Lee JB</pubmed_authors><pubmed_authors>Shin E</pubmed_authors><pubmed_authors>Song WJ</pubmed_authors><pubmed_authors>Kwon HS</pubmed_authors><pubmed_authors>An J</pubmed_authors><pubmed_authors>Kim TB</pubmed_authors><pubmed_authors>Park SY</pubmed_authors><pubmed_authors>Jin J</pubmed_authors><pubmed_authors>Yoo YS</pubmed_authors><pubmed_authors>Lee JH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Impact of asthma, chronic obstructive pulmonary disease (COPD), and asthma-COPD overlap on the prognosis of coronavirus disease 2019.</name><description>&lt;h4>Background&lt;/h4>The effects of asthma, chronic obstructive pulmonary disease (COPD), or asthma-COPD overlap (ACO) on coronavirus disease 2019 (COVID-19) remain unclear.&lt;h4>Objective&lt;/h4>We aimed to investigate the effects of chronic obstructive airway diseases such as asthma, COPD, and ACO on COVID-19.&lt;h4>Methods&lt;/h4>In total, 5625 hospitalized patients with COVID-19 were divided into asthma, COPD, ACO, and control groups. A multivariate logistic regression analysis was performed to identify factors affecting the COVID-19 mortality rate. To find out whether chronic obstructive airway diseases such as asthma, COPD, and ACO affect COVID-19 mortality, 1:4 matching was performed, except for the ACO group alone due to a small number of patients.&lt;h4>Results&lt;/h4>The mortality rates of asthma, </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-22T15:05:17.436Z</modification><creation>2025-02-19T00:56:19.227Z</creation></dates><accession>S-EPMC9066077</accession><cross_references><pubmed>35571550</pubmed><doi>10.5415/apallergy.2022.12.e21</doi></cross_references></HashMap>